Athira pharma to participate in the 2023 cantor fitzgerald global healthcare conference

Bothell, wash., sept. 19, 2023 (globe newswire) -- athira pharma, inc.  (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that company management will participate in a panel presentation at the 2023 cantor fitzgerald global healthcare conference taking place from september 26-28, 2023 in new york city. details are as follows:
ATHA Ratings Summary
ATHA Quant Ranking